Health Care • Hospital/Nursing Management
$29.18 ▲ +0.27
(+0.93%)
MKT CAP: $2.37B • VOL: 832.6K
52W L $17 52W H $31
ROARABLE / RQD
B • 74/100
PIOTROSKI
6 / 9
MD // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $208.8M | -$68.7M | $7.3M |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $165.4M | -$99.1M | -$60.4M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $271.1M | $206.6M | $137.3M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $271.1M | $206.6M | $137.3M |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | 33.6% | -10.1% | — |
| Cash & Short-Term Equivalents | $375.2M | $229.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $865.9M | $764.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR MD.